NCT07826520

Brief Summary

Fibromyalgia is a chronic condition that commonly causes widespread pain, fatigue, and difficulty in daily activities. These symptoms may change from day to day, even when their average severity is similar. This study aims to examine whether daily changes in pain and fatigue are related to functional impact in adults with fibromyalgia. Participants will complete clinical questionnaires at the first visit and record their pain and fatigue levels for seven days. Sleep quality and perceived control over symptoms will also be recorded. No treatment or additional medical procedure will be given as part of the study.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
5mo left

Started Aug 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress33%
Aug 2026Feb 2027

Study Start

First participant enrolled

August 1, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 17, 2026

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2027

Last Updated

September 17, 2026

Status Verified

September 1, 2026

Enrollment Period

7 months

First QC Date

September 12, 2026

Last Update Submit

September 12, 2026

Conditions

Keywords

Symptom FluctuationFibromyalgia Impact QuestionnaireCentral SensitizationSleep QualityFibromyalgia

Outcome Measures

Primary Outcomes (1)

  • Functional Impact Assessed by the Fibromyalgia Impact Questionnaire

    Functional impact will be assessed using the Fibromyalgia Impact Questionnaire (FIQ). The total score ranges from 0 to 100, with higher scores indicating greater impact of fibromyalgia. The main analysis will examine whether within-person variability in pain and fatigue over seven days is associated with the FIQ score independently of average pain and fatigue levels.

    At the initial visit

Secondary Outcomes (4)

  • Within-Person Association Between Pain and Fatigue

    During the 7-day monitoring period

  • Maximum Pain and Fatigue Levels

    During the 7-day monitoring period

  • Perceived Symptom Control

    During the 7-day monitoring period

  • Sleep Quality

    During the 7-day monitoring period

Study Arms (1)

Adults With Fibromyalgia

Adults aged 18-65 years who meet the 2016 American College of Rheumatology criteria for fibromyalgia will be included. Participants will complete clinical questionnaires at the initial visit and record pain and fatigue levels for seven days. Sleep quality and perceived symptom control will also be recorded. No treatment or experimental intervention will be administered as part of the study.

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will consist of adults aged 18-65 years who attend the Physical Medicine and Rehabilitation outpatient clinic of Mardin Training and Research Hospital and meet the 2016 American College of Rheumatology criteria for fibromyalgia. Both female and male participants will be included. All participants must be able to complete the seven-day symptom records and provide written informed consent. No healthy control group will be included.

You may qualify if:

  • Diagnosis of fibromyalgia according to the 2016 American College of Rheumatology criteria
  • Age between 18 and 65 years
  • Ability to understand and complete the daily symptom records
  • Ability and willingness to provide written informed consent

You may not qualify if:

  • Active inflammatory rheumatic disease
  • Major neurological disease
  • Major change in fibromyalgia treatment within the previous three months
  • Pregnancy, postpartum period, or breastfeeding
  • Cognitive impairment or inability to provide informed consent
  • Completion of less than 70% of the required daily symptom records
  • Major change in fibromyalgia treatment during the seven-day monitoring period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mardin Training and Research Hospital

Mardin, 47100, Turkey (Türkiye)

RECRUITING

Related Publications (3)

  • Bartley EJ, Robinson ME, Staud R. Pain and Fatigue Variability Patterns Distinguish Subgroups of Fibromyalgia Patients. J Pain. 2018 Apr;19(4):372-381. doi: 10.1016/j.jpain.2017.11.014. Epub 2017 Dec 15.

    PMID: 29253551BACKGROUND
  • Affleck G, Urrows S, Tennen H, Higgins P, Abeles M. Sequential daily relations of sleep, pain intensity, and attention to pain among women with fibromyalgia. Pain. 1996 Dec;68(2-3):363-8. doi: 10.1016/s0304-3959(96)03226-5.

    PMID: 9121825BACKGROUND
  • Harris RE, Williams DA, McLean SA, Sen A, Hufford M, Gendreau RM, Gracely RH, Clauw DJ. Characterization and consequences of pain variability in individuals with fibromyalgia. Arthritis Rheum. 2005 Nov;52(11):3670-4. doi: 10.1002/art.21407.

    PMID: 16258905BACKGROUND

MeSH Terms

Conditions

FibromyalgiaSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersMental Disorders

Central Study Contacts

Taha Yasin YILDIRIM, M.D.

CONTACT

Hatice Gözde Sümer, M.D.

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
M.D.

Study Record Dates

First Submitted

September 12, 2026

First Posted

September 17, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

February 15, 2027

Study Completion (Estimated)

February 15, 2027

Last Updated

September 17, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations